Biopeptide-EL is a palmitoyl oligopeptide comprised of Pal-VGVVAPG. The peptide acts on the
growth factor TGFβ to stimulate fibrillogenesis. A cream marketed by Sederma also contains inactive ingredients glyceryl polymethacrylate and PEG-8 in addition to the oligopeptide as viscosity and texturing
agents.
